The possibility of using gastroenteroprotector rebamipide to improve the antithrombotic therapy safety
Antithrombotic drugs (antiplatelet agents and anticoagulants) are widely used in cardiological practice for primary and secondary prevention of thrombotic/thromboembolic complications, however, the use of such drugs is associated with the increased risk of hemorrhagic complications, including gastro...
Saved in:
Main Authors: | Natalya M. Vorobyeva (Author), Irina P. Malaya (Author), Vadim D. Zakiev (Author), Olga N. Tkacheva (Author) |
---|---|
Format: | Book |
Published: |
LLC "MEDIAFORMAT",
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023) -
Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients?
by: N. M. Vorobyeva, et al.
Published: (2024) -
Gastrointestinal protection options for direct oral anticoagulants in patients with atrial fibrillation
by: Natalya M. Vorobyeva, et al.
Published: (2022) -
Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of Bleeding
by: N. M. Vorobyeva, et al.
Published: (2023) -
ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
by: O. V. Shatalova, et al.
Published: (2015)